Position in NVCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,969,131
+$220,751 QoQ
Shares Held
384,105
+5.5% QoQ
Ownership
1.45%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. NVCT ranks #248 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in NVCT
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,969,131 | 384,105 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,748,380 | 364,024 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,960,912 | 325,733 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,131,429 | 285,332 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,322,203 | 135,333 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $428,704 | 79,243 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $501,412 | 79,716 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $336,926 | 53,227 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,103,129 | 134,528 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,098,019 | 131,657 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,671,356 | 129,663 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,797,199 | 112,536 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $459,138 | 35,022 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $235,260 | 31,368 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $222,916 | 31,441 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $268,430 | 23,967 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $109,831 | 14,822 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||